Microsoft Word search phase 3 Title Page Amendment

Diabetes Care 2010 Mar 18. 
12.
 
Klein BE, Knudtson MD, Tsai MY, Klein R. The relation of markers of inflammation and 
endothelial dysfunction to the prevalence and progression of diabetic retinopathy: 
Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2009 
Sep;127(9):1175-82. 
13.
 
Rosolowsky ET, Niewczas MA, Ficociello LH, Perkins BA, Warram JH, Krolewski AS. 
Between hyperfiltration and impairment: demystifying early renal functional changes in 
diabetic nephropathy. Diabetes Res Clin Pract 2008 Nov 13;82 Suppl 1:S46-S53. 
14.
 
Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal 
dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006 
Jun;55(6):1832-9. 
15.
 
Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of 
albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003 Jun 
25;289(24):3273-7. 
16.
 
Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. 
Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003 Jun 5;348(23):2285-
93. 
17.
 
Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH. Remission of nephrotic-
range albuminuria in type 1 diabetic patients. Diabetes Care 2001 Nov;24(11):1972-7. 
18.
 
Caramori ML, Fioretto P, Mauer M. Enhancing the predictive value of urinary albumin for 
diabetic nephropathy. J Am Soc Nephrol 2006 Feb;17(2):339-52. 
19.
 
Maahs DM, Snell-Bergeon JK, Hokanson JE, Kinney GL, Berl T, Rewers M, Ogden LG. 
Relationship between cystatin C and coronary artery atherosclerosis progression differs by 
type 1 diabetes. Diabetes Technol Ther 2010 Jan;12(1):25-33. 
20.
 
Andersen TB, Erlandsen EJ, Frokiaer J, Eskild-Jensen A, Brochner-Mortensen J. 
Comparison of within- and between-subject variation of serum cystatin C and serum 
creatinine in children aged 2-13 years. Scand J Clin Lab Invest 2010 Feb;70(1):54-9. 
21.
 
Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH. 
Detection of renal function decline in patients with diabetes and normal or elevated GFR by 
serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. 
J Am Soc Nephrol 2005 May;16(5):1404-12. 
22.
 
Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL. New 
equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009 Mar;20(3):629-
37. 

---

Section 5B - Data Collection (Phase 3 - 1/2011, rev. 8/2011) 
Section 5B - Page 13 
 Cohort 
Study
 
23.
 
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, III, Feldman HI, Kusek JW, 
Eggers P, Van LF, Greene T, Coresh J. A new equation to estimate glomerular filtration 
rate. Ann Intern Med 2009 May 5;150(9):604-12. 
24.
 
Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, Sarnak MJ. CKD 
classification based on estimated GFR over three years and subsequent cardiac and mortality 
outcomes: a cohort study. BMC Nephrol 2009;10:26. 
25.
 
Baron AD QM: Insulin action and endothelial function. In Insulin Resistance:  the 
Metabolic Syndrome X. A.RGaL, Ed. Totowa, NJ: Humana Press, 1999, p. 247-263. 
26.
 
Solberg LA, Eggen DA: Localization and sequence of development of atherosclerotic 
lesions in the carotid and vertebral arteries. Circulation 43:711-724, 1971. 
27.
 
Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR: Pressure amplification explains 
why pulse pressure is unrelated to risk in young subjects. Hypertension 38:1461-1466, 2001. 
28.
 
Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ: The influence of 
heart rate on augmentation index and central arterial pressure in humans. J Physiol 525 Pt 
1:263-270, 2000. 
29.
 
Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ: 
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave 
analysis. J Hypertens 16:2079-2084, 1998. 
30.
 
Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy 
in the diabetes clinic. Diabetes Care 2001 Feb;24(2):250-6. 
31.
 
Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening 
instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006 Jul;108(5):477-
81. 
32.
 
Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The 
DCCT Research Group. Am J Med 1991 Apr;90(4):450-9. 
33.
 
Svoren BM, Volkening LK, Butler DA, Moreland EC, Anderson BJ, Laffel LM. Temporal 
trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes. J Pediatr 
2007 Mar;150(3):279-85. 
34.
 
Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, 
Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV. Factors 
predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. 
Diabetes Care 2009 Nov;32(11):1947-53. 
35.
 
Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-
Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, 
Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer 

---

Section 5B - Data Collection (Phase 3 - 1/2011, rev. 8/2011) 
Section 5B - Page 14 
 Cohort 
Study
 
S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and 
intensive treatment of type 1 diabetes. N Engl J Med 2008 Oct 2;359(14):1464-76. 
36.
 
Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The PedsQL in 
type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory 
Generic Core Scales and type 1 Diabetes Module. Diabetes Care 2003 Mar;26(3):631-7. 
37.
 
Radloff L. The CES-D scale: a self report depression scale for research in the general 
population. Applied Psychological Measurement 1977;1(3):385-401. 
38.
 
Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese 
AD, Bell RA, Waitzfelder BE, McKeown RE. Prevalence and correlates of depressed mood 
among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 2006 
Apr;117(4):1348-58. 
39.
 
Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: 
quantification, validation, and utilization. Diabetes Care 1987 Sep;10(5):617-21. 
40.
 
Green LB, Wysocki T, Reineck BM. Fear of hypoglycemia in children and adolescents with 
diabetes. J Pediatr Psychol 1990 Oct;15(5):633-41. 
41.
 
Clarke WL, Gonder-Frederick A, Snyder AL, Cox DJ. Maternal fear of hypoglycemia in 
their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1998 
Mar;11 Suppl 1:189-94. 
42.
 
Markowitz JT, Butler DA, Volkening LK, Antisdel JE, Anderson BJ, Laffel LM. Brief 
screening tool for disordered eating in diabetes: internal consistency and external validity in 
a contemporary sample of pediatric patients with type 1 diabetes. Diabetes Care 
2010;33:495-500. 
43.
 
Goebel-Fabbri AE, Fikkan J, Franko DL, Pearson K, Anderson BJ, Weinger K. Insulin 
restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes 
Care 2008;31:415-9. 
44.
 
Rubin, RR, Young-Hyman, D, and Peyrot, M. Parent-child responsibility and conflict in 
diabetes care. <[11] Journal> 1989;38:7A. 
45.
 
American Diabetes Association. Report of the expert committee on the diagnosis and 
classification of diabetes mellitus. Diabetes Care 1997;7:1183-97. 
46.
 
Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes 
Care 1999 Dec;22(12):1971-7. 
47.
 
Tisnado DM, Adams JL, Liu H, Damberg CL, Chen WP, Hu FA, Carlisle DM, Mangione 
CM, Kahn KL. What is the concordance between the medical record and patient self-report 
as data sources for ambulatory care? Med Care 2006 Feb;44(2):132-40. 

---

SEARCH Phase 3 Protocol - Section 6A 
Registry Study 
Statistical Considerations 
Table of Contents